natgillin/translations-raw huggingface dataset:
Pre-filled pens are for single use only and should be discarded after use.
Napunjene brizgalice su za jednokratnu upotrebu i treba ih baciti nakon upotrebe.
Pre-filled pens containing 0.3 ml, 0.4 ml, 0.5 ml, 0.6 ml, 0.7 ml, 0.8 ml, 0.9 ml or 1.0 ml solution for injection.
Napunjene brizgalice koje sadrže 0,3 ml, 0,4 ml, 0,5 ml, 0,6 ml, 0,7 ml, 0,8 ml, 0,9 ml ili 1,0 ml otopine za injekciju.
pre-filled pens pre-filled
5 napunjenih brizgalica
pre-filled pens pre-filled pens
3 napunjene
pre-filled pens pre-filled pens
napunjene brizgalice napunjenih
pre-filled pens, each containing 40 mg adalimumab 2 alcohol pads
napunjene brizgalice, svaka sadrži 40 mg adalimumaba 2 jastučića natopljena alkoholom
pre-filled SensoReady pen 2 pre-filled SensoReady pens
napunjena SensoReady brizgalica 2 napunjene SensoReady brizgalice
pre-filled SensoReady pens.
napunjene SensoReady brizgalice.
Pre-filled sterile water syringe x1
Napunjenu štrcaljku sa sterilnom vodom x1
pre-filled syringe
1 napunjena štrcaljka
PRE-FILLED SYRINGE
NAPUJENA ŠTRCALJKA
pre-filled syringe
Napunjena
pre-filled syringe
Napunjena štrcaljka (staklena)
Pre-filled syringe
Napunjena štrcaljka.
pre-filled syringe
štrcaljka (staklo) napunjena
pre-filled syringe
štrcaljka s uloškom (staklena)
pre-filled syringe (glass)
1 ml suspenzije u bočici (staklo tip I) sa čepom klipa (butil guma).
pre-filled syringe (glass)
bočica (staklo)
pre-filled syringe (glass)
napunjena
pre-filled syringe (glass)
napunjena štrcaljka
Pre-filled syringe (glass)
Napunjena štrcaljka (stakla)
Pre-filled syringe (glass)
Napunjena štrcaljka (staklena)
Pre-filled Syringe (glass)
Napunjena štrcaljka (staklo)
pre-filled syringe (glass)
napunjena štrcaljka (staklo) napunjena
pre-filled syringe (glass)
napunjena štrcaljka (staklo) napunjena štrcaljka
pre-filled syringe (glass)
Napunjena štrcaljka(sta klo)
Pre-filled syringe (glass)
Staklo tipa I
pre-filled syringe (glass)
Suspenzija za injekciju u napunjenoj štrcaljki 1 štrcaljka
pre-filled syringe (glass)
Suspenzija za injekciju u napunjenoj štrcaljki 10 štrcaljka
pre-filled syringe (glass)
Suspenzija za injekciju u napunjenoj štrcaljki 25 štrcaljki
pre-filled syringe (glass)
uloškom (staklena) štrcaljka s
Pre-filled syringe (glass)
Štrcaljka s uloškom (staklo)
pre-filled syringe (glass)
štrcaljka
pre-filled syringe (glass)
štrcaljka (staklo)
pre-filled syringe (glass)
štrcaljka (staklo) napunjena
pre-filled syringe (glass)
štrcaljka s uloškom (staklena) štrcaljka s
pre-filled syringe (glass) in pre- filled pen
Napunjena štrcaljkom (stakla) u napunjena brizgalica
pre-filled syringe (glass) pre-filled syringe (glass) pre-filled syringe (glass) pre-filled syringe (glass) pre-filled syringe (glass) pre-filled syringe (glass) pre-filled syringe (glass) pre-filled syringe (glass) pre-filled syringe (glass) pre-filled syringe (glass) pre-filled
napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo) napunjena štrcaljka (staklo)
pre-filled syringe (glass) with needle guard
napunjena štrcaljka (staklena)
pre-filled syringe (glass) with needle guard
napunjena štrcaljka (staklo) sa štitnikom za iglu
pre-filled syringe (glass) with needle guard
Napunjena štrcaljka(sta klo) sa štitnikom za iglu
pre-filled syringe (glass) with needle-trap pre-filled syringe
štrcaljka (staklo) sa štitnikom igle Napunjena
pre-filled syringe (glass) with safety device
napunjena štrcaljka
pre-filled syringe (glass) with safety needle
napunjena štrcaljka
pre-filled syringe (glass) without blister
napunjena štrcaljka (staklena)
pre-filled syringe (glass) without blister
napunjena štrcaljka (staklo) bez blistera
pre-filled syringe (glass) without safety device
napunjena štrcaljka
Pre-filled syringe (HDPE)
Unaprijed napunjena štrcaljka (HDPE)
Pre-filled syringe (PP)
Napunjena štrcaljka (PP)
Pre-filled syringe (Type I glass) with a tip cap and a plunger stopper (teflonised rubber) with an injection needle (27G1/2).
Napunjena štrcaljka (staklo tip I) sa zatvaračem vrha i čepom klipa (guma obložena teflonom) i iglom za injekciju (27G1/2).
Pre-filled syringe (Type I glass) with a tip cap and a plunger stopper (teflonised rubber) with an injection needle (30G1/2).
Napunjena štrcaljka (staklo tip I) sa zatvaračem vrha i čepom klipa (guma obložena teflonom) i iglom za injekciju (30G1/2).
Pre-filled syringe (type I glass) with laminated plunger stopper (bromobutyl rubber) and tip cap (bromobutyl rubber) and a needle 27G1/2, containing 0.3 ml solution.
Napunjena štrcaljka (staklo tipa I) s laminiranim čepom klipa (brombutil guma) i zatvaračem vrha (brombutil guma), koja sadrži 0,3 ml otopine, te jedna igla 27G1/2.
Pre-filled syringe (type I glass) with laminated plunger stopper (bromobutyl rubber) and tip cap (bromobutyl rubber) and a needle 27G1/2, containing 0.6 ml solution.
Napunjena štrcaljka (staklo tipa I) s laminiranim čepom klipa (brombutil guma) i zatvaračem vrha (brombutil guma), koja sadrži 0,6 ml otopine, te jedna igla 27G1/2.
Pre-filled syringe (type I glass), with injection needle (stainless steel) with a needle guard, containing 0.2 ml solution for injection/ infusion.
Napunjena štrcaljka (staklo tipa I) s iglom za injekciju (nehrđajući čelik) i štitnikom za iglu, koja sadrži 0,2 ml otopine za injekciju/infuziju.
Pre-filled syringe (type I glass), with injection needle (stainless steel) with a needle guard, containing 0.5 ml solution for injection/ infusion
Jedna napunjena štrcaljka (staklo tipa I), s iglom za injekciju (nehrđajući čelik) sa štitnikom za iglu, sadržavajući 0,5 ml otopine za injekciju/infuziju
Pre-filled syringe - 300 mg
Napunjena štrcaljka - 300 mg
Pre-filled syringe - 400 mg
Napunjena štrcaljka - 400 mg
PRE-FILLED SYRINGE / PRE-FILLED SYRINGE WITH A NEEDLE SAFETY GUARD
NAPUNJENA ŠTRCALJKA / NAPUNJENA ŠTRCALJKA SA SIGURNOSNOM ZAŠTITOM ZA IGLU
Pre-Filled Syringe 125 mcg
Napunjena štrcaljka od 125 μg
pre-filled syringe 2 pre-filled syringes
napunjena štrcaljka 2 napunjene štrcaljke
Pre-filled syringe 75 mg:
Napunjena štrcaljka od 75 mg:
PRE-FILLED SYRINGE BLISTER
BLISTER ZA NAPUNJENU ŠTRCALJKU
PRE-FILLED SYRINGE CARTON
KUTIJA NAPUNJENE ŠTRCALJKE
PRE-FILLED SYRINGE CARTON
KUTIJA S NAPUNJENOM ŠTRCALJKOM
PRE-FILLED SYRINGE CARTON
KUTIJA ZA NAPUNJENU ŠTRCALJKU
PRE-FILLED SYRINGE CARTON (WITH BLUE BOX) - Multipack
KUTIJA ZA NAPUNJENU ŠTRCALJKU (S PLAVIM OKVIROM) – Višestruko pakiranje
PRE-FILLED SYRINGE CARTON (WITHOUT BLUE BOX) - Multipack
KUTIJA ZA NAPUNJENU ŠTRCALJKU (BEZ PLAVOG OKVIRA) – Višestruko pakiranje
PRE-FILLED SYRINGE CARTON TEXT (45 mg)
TEKST NA KUTIJI ZA NAPUNJENE ŠTRCALJKE (45 mg)
PRE-FILLED SYRINGE CARTON TEXT (90 mg)
TEKST NA KUTIJI ZA NAPUNJENE ŠTRCALJKE (90 mg)
PRE-FILLED SYRINGE CARTON WITH TRAY
KUTIJA S NAPUNJENIM ŠTRCALJKAMA S PODLOŠKOM
PRE-FILLED SYRINGE CARTON WITHOUT TRAY
KUTIJA ZA NAPUNJENE ŠTRCALJKE BEZ PODLOŠKA
pre-filled syringe containing 40 mg adalimumab 1 alcohol pad
napunjena štrcaljka sadrži 40 mg adalimumaba 1 jastučić natopljen alkoholom
Pre-filled syringe containing clear, colourless solvent (water for injections) Syringe plunger
Napunjena štrcaljka s prozirnim, bezbojnim otapalom (voda za injekcije) Klip štrcaljke
Pre-Filled Syringe Double Lid 125 mcg
Pakiranje s napunjenom štrcaljkom od 125 μg i dvostrukim poklopcem
Pre-Filled Syringe Double Lid Initiation Pack
Početno pakiranje s napunjenim štrcaljkama i dvostrukim poklopcem
Pre-filled syringe EU/1/00/152/001 EU/1/00/152/002 EU/1/00/152/003 EU/1/00/152/004 EU/1/00/152/005 EU/1/00/152/006 EU/1/00/152/007 EU/1/00/152/008 EU/1/00/152/021
Napunjena štrcaljka EU/1/00/152/001 EU/1/00/152/002 EU/1/00/152/003 EU/1/00/152/004 EU/1/00/152/005 EU/1/00/152/006 EU/1/00/152/007 EU/1/00/152/008 EU/1/00/152/021
PRE-FILLED SYRINGE FOR SOLVENT 3 ml water for injections
NAPUNJENA ŠTRCALJKA ZA OTAPALO 3 ml voda za injekcije
PRE-FILLED SYRINGE FOR SOLVENT 4.2 ml water for injections
NAPUNJENA ŠTRCALJKA ZA OTAPALO 4,2 ml voda za injekcije
Pre-Filled Syringe Initiation Pack
Početno pakiranje s napunjenim štrcaljkama
PRE-FILLED SYRINGE LABEL
NALJEPNICA ZA NAPUNJENA ŠTRCALJKA
PRE-FILLED SYRINGE LABEL (BLISTERED)
NALJEPNICA NA NAPUNJENOJ ŠTRCALJKI (U BLISTERU)
PRE-FILLED SYRINGE LABEL (UNBLISTERED)
NALJEPNICA NAPUNJENE ŠTRCALJKE (BEZ BLISTERA)
Pre-Filled Syringe Label 125 mcg
Naljepnica na napunjenoj štrcaljki od 125 μg
PRE-FILLED SYRINGE LABEL FOR THE SOLVENT
NALJEPNICA NA NAPUNJENOJ ŠTRCALJKI S OTAPALOM
Pre-Filled Syringe Label Initiation Pack
Naljepnica na napunjenoj štrcaljki u početnom pakiranju
Pre-filled syringe label text
Tekst na naljepnici napunjene štrcaljke
Pre-filled syringe label text
Tekst na naljepnici za napunjenu štrcaljku
PRE-FILLED SYRINGE LABEL WHEN USED WITH TRAY
NALJEPNICA NA NAPUNJENOJ ŠTRCALJKI S PODLOŠKOM
pre-filled syringe needles
napunjena štrcaljka igle
pre-filled syringe of 0.65 ml solvent 1 vial connector injection needles
napunjenu štrcaljku s 0,65 ml otapala 1 priključak za bočicu igle za injekciju
Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.
0,3 ml otopine u napunjenoj štrcaljki od stakla tipa I, s pričvršćenom čeličnom iglom za injekciju i čepom klipa obloženim politetrafluoroetilenom (PTFE-om) sa ili bez štitnika za iglu ili s klopkom za iglu.
Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.
0,4 ml otopine u napunjenoj štrcaljki sa staklom tipa I, s pričvršćenom čeličnom iglom za injekciju i čepom klipa obloženim politetrafluoroetilenom (PTFE-om) sa ili bez štitnika za iglu ili s klopkom za iglu.
Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.
0,5 ml otopine u napunjenoj štrcaljki od stakla tipa I, s pričvršćenom čeličnom iglom za injekciju i čepom klipa obloženim politetrafluoroetilenom (PTFE-om) sa ili bez štitnika za iglu ili s klopkom za iglu.
Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.
0,6 ml otopine u napunjenoj štrcaljki od stakla tipa I, s pričvršćenom čeličnom iglom za injekciju i čepom klipa obloženim politetrafluoroetilenom (PTFE-om) sa ili bez štitnika za iglu ili s klopkom za iglu.
Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.
0,75 ml otopine u napunjenoj štrcaljki od stakla tipa I, s pričvršćenom čeličnom iglom za injekciju i čepom klipa obloženim politetrafluoroetilenom (PTFE-om) sa ili bez štitnika za iglu ili s klopkom za iglu.
Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.
0,8 ml otopine u napunjenoj štrcaljki od stakla tipa I, s pričvršćenom čeličnom iglom za injekciju i čepom klipa obloženim politetrafluoroetilenom (PTFE-om) sa ili bez štitnika za iglu ili s klopkom za iglu.
Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.
0,9 ml otopine u napunjenoj štrcaljki od stakla tipa I, s pričvršćenom čeličnom iglom za injekciju i čepom klipa obloženim politetrafluoroetilenom (PTFE-om) sa ili bez štitnika za iglu ili s klopkom za iglu.
Pre-filled syringe Type I glass with a fixed steel injection needle and a plunger stopper with PTFE coating with or without a needle guard or needle-trap device.
1 ml otopine u napunjenoj štrcaljki od stakla tipa I, s pričvršćenom čeličnom iglom za injekciju i čepom klipa obloženim politetrafluoroetilenom (PTFE-om) sa ili bez štitnika za iglu ili s klopkom za iglu.
Pre-filled syringe with 2 needles, pack of 1, 10
Napunjena štrcaljka s 2 igle, pakiranje od 1, 10
PRE-FILLED SYRINGE WITH 2.5 mL or 5 mL WATER FOR INJECTIONS
NAPUNJENA ŠTRCALJKA S 2,5 ml ILI 5 ml VODE ZA INJEKCIJE
PRE-FILLED SYRINGE WITH 2.5 ML WATER FOR INJECTIONS
NAPUNJENA ŠTRCALJKA S 2,5 ML VODE ZA INJEKCIJE
Pre-filled syringe with injection needle, with or without a needle safety guard.
Napunjena štrcaljka s iglom za injekciju, sa ili bez sigurnosnog štitnika za iglu.
Pre-filled syringe with needle safety guard
Napunjena štrcaljka sa sigurnosnim štitnikom za iglu
Pre-filled syringe with needle safety guard
Napunjena štrcaljka sa zaštitnim mehanizmom za iglu
PRE-FILLED SYRINGE WITH WATER FOR INJECTIONS
NAPUNJENA ŠTRCALJKA S VODOM ZA INJEKCIJE
Pre-filled syringe without needle safety guard
Napunjena igla bez sigurnosnog štitnika za iglu
Pre-filled syringe without needle safety guard
Napunjena štrcaljka bez zaštitnog mehanizma za iglu
PRE-FILLED SYRINGE WITHOUT NEEDLES: PACK OF 10
NAPUNJENA ŠTRCALJKA BEZ IGLE: PAKIRANJE 10 KOM.
Pre-filled syringe: Removab 10 micrograms
Napunjena štrcaljka: Removab 10 mikrograma
Pre-filled syringe: Removab 50 micrograms
Napunjena štrcaljka: Removab 50 mikrograma
Pre-filled syringe: Type I glass barrel with a polypropylene backstop and bromobutyl rubber plunger.
Napunjena štrcaljka: Spremnik od stakla tipa I s polipropilenskim graničnikom i brombutilnim gumenim klipom.
PRE-FILLED SYRINGES
NAPUNJENE ŠTRCALJKE
Pre-filled syringes (glass type I), with or without a needle safety guard, with plunger stopper (Teflon- faced rubber) sealed in a blister.
Napunjene štrcaljke (staklo tip I), sa ili bez sigurnosnog štitnika za iglu, s čepom klipa (teflonom prekrivena guma), zatvorene u blisteru.
pre-filled syringes 6 pre-filled syringes
napunjene štrcaljke 6 napunjenih štrcaljki
Pre-filled syringes are for single use only and should be discarded after use.
Napunjene štrcaljke su za jednokratnu upotrebu i treba ih baciti nakon upotrebe.
PRE-FILLED SYRINGES TEXT Orgalutran 0.25 mg/0.5 mL
TEKST NA NAPUNJENOJ ŠTRCALJKI Orgalutran 0,25 mg/0,5 ml
pre-filled syringes with needle guard
napunjene štrcaljke sa štitnikom za iglu
Pre-filled syringes*
Napunjene štrcaljke
pre-filled syringes, each containing 40 mg adalimumab 2 alcohol pads
napunjene štrcaljke, svaka sadrži 40 mg adalimumaba 2 jastučića natopljena alkoholom
pre-filled syringes.
napunjene štrcaljke.
Pre-gelatinised maize starch
kukuruzni škrob prethodno geliran
Pre-infusion check-list
Predinfuzijski kontrolni upitnik
Pre-infusion medications should be administered to reduce the risk of infusion-related reactions (IRRs) prior to treatment with DARZALEX.
Prije liječenja lijekom DARZALEX potrebno je primijeniti lijekove za smanjenje rizika od reakcija na infuziju.
Pre-infusion medications should be administered to reduce the risk of IRRs to all patients approximately 1 hour prior to every infusion of DARZALEX as follows:
Približno 1 sat prije svake infuzije lijeka DARZALEX, svim se bolesnicima moraju primijeniti lijekovi za smanjenje rizika od reakcija na infuziju, kako slijedi:
Pre-medications attenuate infusion reactions but these may still occur, predominantly during the first infusion.
Premedikacija ublažava reakcije na infuziju, ali se one i dalje mogu dogoditi, osobito tijekom prve infuzije.
Pre-Menopausal
Premenopauza
Pre-moisten the flat TachoSil matrix in saline solution and place it on the wound immediately (if the wound is completely wetted by blood and other fluids, there is no need to moisten the matrix before application).
Navlažite ravnu Tachosil matricu fiziološkom otopinom i odmah je položite na ranu (ako je rana potpuno vlažna od krvi i drugih tekućina, matricu prije primjene nije potrebno vlažiti).
Pre-planned interim analyses of both studies showed that lenalidomide/dexamethasone was statistically significantly superior (p < 0.00001) to dexamethasone alone for the primary efficacy endpoint, TTP (median follow-up duration of 98.0 weeks).
Prethodno planirane međuanalize za oba ispitivanja pokazale su da je kombinacija lenalidomida/deksametazona statistički značajno superiornija (p < 0,00001) u odnosu na sam deksametazon za primarni ishod, vrijeme do napredovanja bolesti (medijan vremena praćenja u trajanju od 98 tjedana).
Pre-planned Interim Analysis (35% OS
Unaprijed planirana međuanaliza (sa 35% podataka za OS)
Pre-planned OS analysis (conducted at the time of the final PFS analysis, 03 June 2008)
Unaprijed isplanirana analiza OS-a (provedena u vrijeme završne PFS analize, 03. lipnja 2008.)
Pre-procedure prevention of angioedema attacks
Prevencija napadaja angioedema prije zahvata
Pre-specified Efficacy Evaluable Analysis
Unaprijed određena analiza djelotvornosti koja se mogla procijeniti
Pre-specified interim analysis
Unaprijed određena privremena analiza
Pre-specified interim analysis
Unaprijed planirana interim analiza
Pre-specified ITT Analysis
Unaprijed određena analiza populacije planirane za liječenje
Pre-specified subgroup analyses for both PFS and OS according to age (<65 and ≥65 years), gender, race, ECOG PS (0 or ≥1), number of organs involved, liver metastases only, site of primary tumour (colon or rectum), carcinoembryonic antigen levels (<200 μg/L, ≥200 μg/L), all showed a treatment effect favouring Cyramza plus FOLFIRI treatment over placebo plus FOLFIRI.
Sve unaprijed određene analize podskupina za PFS i OS – prema dobi (< 65 i ≥ 65 godina), spolu, rasi, funkcionalnom ECOG statusu (0 ili ≥ 1), broju zahvaćenih organa, metastazama samo u jetri, sijelu primarnog tumora (kolon ili rektum) i vrijednostima karcinoembrijskog antigena (< 200 µg/l, ≥ 200 µ/l) – pokazale su da se bolji terapijski učinak ostvaruje lijekom Cyramza plus protokolom FOLFIRI nego placebom plus protokolom FOLFIRI.
Pre-specified subgroup analyses of the primary endpoint by baseline CRP (≥ 1 mg/dL vs < 1 mg/dL) demonstrated higher flare rates in placebo + MTX vs golimumab + MTX treated subjects among subjects with baseline CRP ≥ 1 mg/dL (87% vs 40% p = 0.0068).
Prethodno definirane analize primarne mjere ishoda podskupine prema početnim vrijednostima CRP-a (≥ 1 mg/dl naspram < 1 mg/dl) pokazale su više stope razbuktavanja bolesti u skupini ispitanika koja je primala placebo + MTX nego u onoj koja je primala Simponi + MTX među ispitanicima s početnim vrijednostima CRP-a ≥ 1 mg/dl (87% naspram 40%, p=0,0068).
Pre-Study Treatment
Liječenje prije ispitivanja
Pre-surgery: calculate dose of Coagadex to raise plasma factor X levels to 70-90 IU/dL.
Prije operativnog zahvata: izračunajte dozu lijeka Coagadex za porast razine faktora X u plazmi na 70-90 IU/dl.
Pre-switching rates (Cycles 1-4) for serious adverse events, grade 3 adverse events and treatment discontinuations due to adverse events were low (<5%) and similar to post-switching rates (Cycles 5- 8).
Stope ozbiljnih štetnih događaja, štetnih događaja 3. stupnja i prekida liječenja zbog štetnih događaja zabilježene prije prelaska (1.-4. ciklus) bile su niske (<5%) i slične onima primijećenima nakon prelaska (5.-8. ciklus).
Pre-treatment Baseline
Početne vrijednosti prije liječenja
Pre-treatment testing for NS3 Q80K polymorphism in patients infected with HCV genotype 1a
Ispitivanje na NS3 Q80K polimorfizam koje prethodi liječenju u bolesnika inficiranih HCV-om genotipa 1a
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment with Loxicom.
Prethodno liječenje protuupalnim tvarima može rezultirati dodatnim ili povećanim nuspojavama, a shodno tome, razdoblje bez liječenja takvim lijekovima mora se pratiti najmanje 24 sata prije početka liječenja.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment.
Prethodna primjena protuupalnih lijekova može rezultirati dodatnim ili pojačanim nuspojavama, tako da treba paziti da se prije početka liječenja takvi veterinarsko-medicinski proizvodi ne primjenjuju najmanje 24 sata.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment.
Prethodno liječenje protuupalnim tvarima može rezultirati dodatnim ili povećanim nuspojavama pa je prema tome potrebno razdoblje bez primjene takvih veterinarsko-medicinskih proizvoda barem 24 sata prije početka liječenja.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment.
Prethodno liječenje protuupalnim tvarima može rezultirati dodatnim ili povećanim nuspojavama, a shodno tome, razdoblje bez liječenja takvim lijekovima mora se pratiti najmanje 24 sata prije početka liječenja.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24 hours before commencement of treatment.
Prethodno liječenje s drugim protuupalnim pripravcima može rezultirati dodatnim ili pojačanim neželjenim popratnim pojavama te takvo liječenje treba prekinuti najmanje 24 sata prije liječenja Meloxidylom.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such medicines should be observed for at least 24 hours before commencement of treatment.
Prethodna primjena protuupalnih lijekova može rezultirati dodatnim ili pojačanim nuspojavama, tako da treba paziti da se takvi veterinarsko-medicinski proizvodi ne primjenjuju najmanje 24 sata prije početka liječenja.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such medicines should be observed for at least 24 hours before commencement of treatment.
Prethodna primjena protuupalnih lijekova može rezultirati dodatnim ili pojačanim nuspojavama, tako da treba paziti da se takvi veterinarsko-medicinski proizvodi ne primjenjuju najmanje 24 sata prije početka liječenja. .
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment.
Prethodna primjena protuupalnih lijekova, može rezultirati dodatnim ili pojačanim nuspojavama, tako da treba paziti da se prije početka liječenja takvi veterinarsko-medicinski proizvodi ne primjenjuju najmanje 24 sata.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary medicinal products should be observed for at least 24 hours before commencement of treatment.
Prethodno liječenje protuupalnim lijekovima može rezultirati dodatnim ili pojačanim nuspojavama, pa se sukladno tome prije početka liječenja mora poštivati razdoblje od 24 sata u kojem se takvi lijekovi ne primjenjuju.
Pre-treatment with anti-inflammatory substances may result in additional or increased adverse effects and accordingly a treatment-free period with such veterinary products should be observed for at least 24 hours before commencement of treatment.
Prethodna primjena protuupalnih lijekova može rezultirati dodatnim ili pojačanim nuspojavama, tako da treba paziti da se prije početka liječenja takvi veterinarsko-medicinski proizvodi ne primjenjuju najmanje 24 sata.